Although it is clear that T helper (Th)17 cells play a pathologic role in the pathogenesis of several inflammatory diseases, the contribution and regulation of pathogenic Th17 cells in the development of glomerulonephritis are still not fully understood. Herein, we show that IL-10edeficient mice exhibit exacerbation of glomerulonephritis after induction with antieglomerular basement membrane globulin, with enhanced pathogenic Th17 immune responses. We further demonstrate that Rag1 
Although it is clear that T helper (Th)17 cells play a pathologic role in the pathogenesis of several inflammatory diseases, the contribution and regulation of pathogenic Th17 cells in the development of glomerulonephritis are still not fully understood. Herein, we show that IL-10edeficient mice exhibit exacerbation of glomerulonephritis after induction with antieglomerular basement membrane globulin, with enhanced pathogenic Th17 immune responses. We further demonstrate that Rag1 T helper (Th)17 cells, which are clearly distinct from Th1 and Th2 cells, have been defined as an additional Th cell subset that mediates proinflammatory and autoimmune responses through the production of Th17 signature cytokines, including IL-17A, IL-17F, and 1e4 Synergy between the cytokines transforming growth factor (TGF)-b and IL-6 induces in vitro development of Th17 cells, 5e8 whereas IL-23 promotes the survival and expansion of Th17 cell populations.
2,5,9,10 IL-23 is also believed to play an important role in the development of pathogenic Th17 cells. 11 Several transcription factors are involved in the regulation of Th17 cell differentiation. Among them, RORgt, a member of the orphan nuclear receptor family, has been identified as the master transcription factor for Th17 cell development. 12 Other transcription factors, including RORa, STAT3, IRF4, and IRF8, are also involved in the control of Th17 cell differentiation. 13 In addition, the differentiation of Th17 cells is also regulated by several positive and negative feedback loops involving IL-21, IL-23R, IL-10, and IL-27. 6,7,14e18 There is increasing evidence that Th17 cells are involved in the pathogenesis of various autoimmune/inflammatory diseases, including multiple sclerosis, rheumatoid arthritis, inflammatory bowel diseases, and asthma. 19 Thus, a more complete understanding of the molecular mechanisms involved in the regulation of Th17 immune responses and its roles in different inflammatory diseases should provide insights into the pathogenesis and treatment of inflammatory diseases.
Glomerulonephritis (GN) is a renal disease observed as inflammation in glomeruli and small blood vessels of the kidneys. 20 The presentation of GN may include hematuria, proteinuria, and a variable degree of renal failure. 20 The mechanisms underlying the pathogenesis of GN are incompletely understood. It has been believed that Th1-mediated immune responses are involved in the development of GN, 21, 22 but more recent studies suggest that Th17 cells instead of Th1 cells contribute to the pathogenesis of GN.
23e26 However, the functions and regulation of Th17 cells in the development of GN still need to be further explored.
IL-10, identified by Mosmann and colleagues in 1989, 27 is a pluripotent cytokine produced by many activated immune cell types, including Th cells, B cells, macrophages, monocytes, and keratinocytes. 28 IL-10 activates through the IL-10 receptor (IL-10R), which is expressed on a variety of cell types. 28 The IL-10R is composed of two chains, IL-10R1 and IL-10R2. 28 Interaction of IL-10 with the IL-10R results in STAT3-mediated signal transduction. 29 IL-10 inhibits Th1 cell differentiation and IL-12 production in macrophages. We recently demonstrated that IL-10 plays a negative role in the regulation of Th17 cell development. 18 IL-10edeficient mice spontaneously develop colitis; a condition once attributed to an enhanced Th1 immune response. Recent studies suggest that Th17 cells may contribute to the development of colitis in IL-10edeficient mice. 30 Kitching et al 31 reported that endogenous IL-10 regulates Th1 immune responses that induce crescentic GN. However, the importance of IL-10 in the regulation of pathogenic Th17 cell differentiation during the development of GN is still not fully understood.
In the present study, we show that mice deficient in IL-10 exhibit more severe GN after induction with antieglomerular basement membrane (aGBM) globulin, with enhanced Th17 immune responses. We further demonstrate that Rag1 À/À mice reconstituted with IL-10 À/À CD4 þ T cells develop more severe GN after induction of aGBM disease, with more infiltration of inflammatory cells into the kidneys. Finally, the IL-17 and interferon (IFN)-g double-positive cell populations were significantly higher in IL-10 À/À CD4 þ T-cell cultures under pathogenic Th17 conditions compared with wild-type (WT) cell cultures, and the double-positive cells were significantly increased in IL-10 À/À mice with GN. These findings suggest that IL-10 plays a critical suppressive role in the control of pathogenic Th17 cell differentiation and highlights the importance of IL-10 as protection against GN development.
Materials and Methods

Mice
C57BL/6J and IL-10edeficient mice were obtained from The Jackson Laboratory (Bar Harbor, ME) and were maintained in the barrier facility at the Icahn School of Medicine at Mount Sinai (New York, NY). The animal study protocols were approved by the Institutional Animal Care and Use Committees of the Icahn School of Medicine at Mount Sinai.
Antibodies
The following antibodies were purchased from BD Biosciences (San Diego, CA), as conjugated to fluorescein isothiocyanate, phosphatidylethanolamine, phosphatidylethanolamine-Cy5, perCP-Cy5.5, or APC: CD4 (L3T4), CD8 (53-6.7), CD3e (145-2C11), CD25 (PC61. 5 
CD4
þ T-Cell Preparation and Differentiation in Vitro 
Assessment of Renal Injuries
Glomerular abnormalities were analyzed on PAS-stained, Bouin-fixed, paraffin-embedded sections (3 mm thick) using coded slides. Abnormalities included crescent formation and severe necrosis. A minimum of 50 glomeruli were analyzed per animal to determine the percentage of crescentic glomeruli. Semiquantitative analysis of tubulointerstitial damage was performed in each mouse as previously published 32,33 using 10 randomly selected cortical areas (Â200). Injury was defined as tubular dilation, tubular atrophy, sloughing of tubular epithelial cells, or thickening of the basement membrane. 32, 33 Each cortical field was scored (0 to 4) according to the amount of injury: 0 indicates no interstitial damage; 1, 25% of the tubulointerstitium damaged;
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The American Journal of Pathology -ajp.amjpathol.org2, 25% to 50% damaged; 3, 50% to 75% damaged; and 4, >75% of the tubulointerstitium damaged. For urine collection, mice were housed for 24 hours in metabolic cages with free access to tap water, whereas serum was collected after the mice were sacrificed. Albuminuria was analyzed by enzyme-linked immunosorbent assay (ELISA) according to the manufacturer's instructions (eBioscience).
Renal Leukocyte Infiltration
Kidney sections were fixed in periodate-lysine-paraformaldehyde for 4 hours, washed with 20% sucrose solution, and then frozen. Tissue sections were cut, and immunofluorescence staining was used to stain for T cells, macrophages, and neutrophils. The antibodies of anti-mouse CD3 (145-2C11), antieMAC-2, and antieGr-1(RB6-8C5) were used as primary antibodies to detect T cells, macrophages, and neutrophils, respectively (BD Biosciences). At least 25 consecutively viewed glomeruli were assessed per animal, and the results were expressed as cells per glomerular cross section.
Intracellular Staining and Flow Cytometry
Cells were stimulated with PMA and ionomycin for 5 hours in the presence of brefeldin A before intracellular staining. Cells were fixed with intracellular fixation buffer (BD Biosciences), incubated with permeabilization buffer, and stained with phosphatidylethanolamineeanti-mouse IL-17, APCeantieIFN-g, and phosphatidylethanolamine-Cy5.5 anti-mouse CD4 antibodies. Flow cytometry was performed using a FACSCalibur system (BD Biosciences).
RNA Isolation and Real-Time RT-qPCR
Total RNA was extracted using an RNeasy Plus kit (Qiagen Inc., Valencia, CA), and cDNA was generated using an oligo (dT) primer and the SuperScript II system (Invitrogen, Carlsbad, CA), followed by analysis using iCycler PCR with SYBR Green PCR master mix (Applied Biosystems, Foster City, CA). Results were normalized based on the expression of ubiquitin. 
Cell Transfer Studies
Splenocytes or CD4 þ T cells from WT and IL-10 À/À mice were injected i.p. into Rag1 À/À recipients (1 Â 10 7 splenocytes or 4 Â 10 6 CD4 þ T cells per mouse in 200 mL of sterile PBS per injection). Mice were then immunized by s.c. injection of 0.5 mg in Freund complete adjuvant, and 5 days later the SG-sensitized mice were i.p. injected with sheep anti-mouse GBM globulin at a dose of 30 mg per mouse. Fourteen days later, renal injury and systemic immune responses were assessed. For evaluation of antigen-specific immune responses, a separate group of mice was weighed every week throughout the course of the experiments. After 5 weeks, the mice were sacrificed and their kidney tissues were excised. The tissues were fixed in 10% buffered formalin and were paraffin embedded. Tissue sections (5 mm thick) were stained with H&E. All the slides were read and scored by an experienced pathologist without previous knowledge of the type of treatment. The degree of inflammation in the epithelium, submucosa, and submuscularis propria was scored separately as described previously. 34 Cytokine ELISA Supernatants from cell cultures were collected after activation under various conditions, and secreted cytokines in the supernatants were measured by ELISA kits with purified 
Statistical Analysis
Statistical analysis was performed using Student's t-test. P < 0.05 was considered statistically significant.
Results
IL-10 Deficiency Exacerbates GN
To investigate the function of IL-10 in the development of GN, we induced GN by using the aGBM disease model. IL-10edeficient mice developed more severe nephritis after injection of aGBM globulin into sensitized mice compared with WT mice ( Figure 1A ). IL-10 À/À mice displayed more severe histologic and functional renal injury and exhibited more glomerular crescents and severe interstitial injury ( Figure 1B ). In addition, IL-10 À/À mice also had more albuminuria and higher serum urea nitrogen levels compared with WT mice ( Figure 1C ). Taken together, the results suggest that anti-inflammatory cytokine IL-10 plays a protective role in the development of GN.
Enhanced Immune Responses in IL-10
À/À Mice with aGBM Disease
Th17 cells are thought to be pathogenic in several inflammatory diseases. As such, a study of Th17 cell development seems critical to understanding disease progression. We began to investigate the development of Th17 cells in WT and IL-10 À/À mice with GN. We prepared splenocytes from WT and IL-10 
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The American Journal of Pathology -ajp.amjpathol.orgT cells was significantly increased in IL-10 À/À cell cultures (14.8%) compared with WT cell cultures (7.4%) ( Figure 3A) . The percentages of IL-4eproducing and Treg cells were comparable in WT and IL-10 À/À cell cultures ( Figure 3A) . Furthermore, IgG levels in WT and IL-10 À/À mice with GN were similar, ruling out B-cell involvement as a cause of IL-10 À/À mice developing worse GN ( Figure 3B ). Real-time PCR analysis indicated that the mRNA expression of signature molecules for Th17 and Th1 cells was significantly enhanced in the kidneys of IL-10 À/À compared with WT mice with GN ( Figure 3C ). Transcript levels of transcription factors (Gata3 and FOXP3) for Th2 and Treg cells, however, were not altered ( Figure 3C ). In addition, IL-10 mRNA expression was slightly increased in WT mice with GN ( Figure 4A ). To investigate IL-10 expression from different effector T cells, we activated naive CD4 þ T cells from C57Bl/6 mice under Th1, Th2, Th17, or Treg cell conditions and found that all these effector T cells express IL-10 ( Figure 4B ). Taken together, these results suggest that IL-10 negatively regulates Th17 and Th1 immune responses in the development of GN.
Transfer of CD4
þ T Cells Induces More Severe GN in RAG1 À/À Mice These data suggest that Th17 cells may be involved in the development of GN in IL-10 À/À mice. Next we wanted to confirm that the disease development is really due to CD4 
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À/À mice developed severe glomerular and interstitial injury ( Figure 6B ) and higher albuminuria and serum urea ( Figure 6C ). Taken together, these results demonstrate that the anti-inflammatory cytokine IL-10 plays an important role in the control of GN development, suggesting that IL-10 could be a therapeutic choice for the treatment of immune-related GN.
IL-10 Regulates Pathogenic Th17 Cell Differentiation in GN
To explore how IL-10 regulates pathogenic Th17 cell development during GN, we focused on Rag1 À/À mice reconstituted with WT and IL-10 À/À CD4 þ T cells followed by immunization with SG for 6 days. We found that recipient mice reconstituted with IL-10 À/À CD4 þ T cells displayed enlarged spleens and increased splenocyte counts ( Figure 7A ) compared with mice transferred with WT CD4 þ T cells. The spleen cells were restimulated with SG for 24 hours, and IL-17eproducing CD4 þ T cells were analyzed by flow cytometry. As expected, the percentage of Th17 cells was significantly higher in mice reconstituted with IL-10 À/À CD4 þ T cells ( Figure 7B ). In addition, significantly more inflammatory cells, including CD3 To further investigate the regulation of pathogenic Th17 cell differentiation by IL-10, we purified naive CD4 þ T cells from the spleens and lymph nodes of WT and IL-10 À/À mice and stimulated the cells under nonpathogenic Th17 conditions (TGF-b1 and IL-6), pathogenic Th17 conditions (TGFb1, IL-6, and IL-23), or Th1 conditions (IL-12) for 3 days. The IL-17eproducing CD4 þ T-cell population was significantly higher in IL-10 À/À cell cultures compared with WT cell cultures ( Figure 8A) . 18 Under pathogenic Th17 conditions, the IL-17 and IFN-g double-positive cell populations also significantly increased, which is similar to the response in IL-17 single-positive cells ( Figure 8A ). In addition, IFNgeproducing cells were moderately increased ( Figure 8A ). IL-17 production and mRNA expression of Th17 signature molecules were also greatly enhanced in IL-10 À/À mice under pathogenic Th17 conditions (Figure 8 , B and C). To confirm that IL-10 regulates the production of Th17 cells in vivo, we prepared cells from the spleens and mesenteric lymph nodes of WT and IL-10 À/À mice with GN and then stimulated those cells with PMA/ionomycin for 6 hours. Stimulated cells were harvested, and the IL-17 and IFN-g double-positive CD4 þ T cells were analyzed by FACS. As expected, the percentage of IL-17 and IFN-g double-positive CD4 þ T cells was significantly higher in IL-10 À/À mice than in WT mice ( Figure 8D ). Taken together, these results suggest that IL-10 derived from T cells regulates pathogenic Th17 cell development in GN.
Discussion
Although Th17 cells have been associated with the pathogenesis of inflammatory diseases, including GN, the regulation of Its genetic ablation or inhibition leads to spontaneous colitis and some other autoimmune and inflammatory diseases. Previously, Kitching et al 31 reported that endogenous IL-10 protects against crescentic GN by suppressing Th1 immune responses. In addition, El-Shemi et al 35 showed that IL-10 gene transfer suppressed experimental GN. 35 However, the exact actions performed by IL-10 in preventing the development of GN are not well known. Recently, the new 
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The American Journal of Pathology -ajp.amjpathol.orgdiagram indicates that Th17 cells instead of Th1 cells play the critical role in the development of inflammatory diseases. Therefore, the role of IL-10 in the development of immune-related GN needs to be revisited. In the present study, we demonstrated that IL-10edeficient mice exhibit worse GN in a mouse model induced with aGBM globulin, with enhanced Th17 immune responses. These results suggest that Th17 immune responses may be involved in the exacerbation of GN in IL-10edeficient mice. IL-10 has been detected in human GN, in which IL-10 mRNA and protein are found in the more severe glomerular lesions. 36 IL-10 mRNA has been detected in the kidneys of rats with accelerated anti-GBM GN. 37 The expression of IL-10 in a disease situation may reflect initiation of protective mechanisms in the context of severe glomerular injury; however, the molecular regulation of IL-10 expression in a disease condition is still not fully understood. IL-10 is produced by different cell types, including macrophages, B cells, mesangial cells, keratinocytes, and T cells. 28 In the present study, we focused on T-celleexpressed IL-10 in the pathogenesis of GN. Because Th1 and Th17 immune responses are significantly strengthened in IL-10 À/À mice, it has been difficult to resolve À/À mice. Taken together, we believe that Th17 and Th1cells regulated by IL-10 may contribute to the worsening of GN in IL-10 À/À mice. However, the relative importance of Th17 and Th1 cells to the development of GN needs to be further explored in future studies.
Although Th17 cells have been associated with the induction of autoimmune/inflammatory diseases, emerging data suggest that not all Th17 cells are pathogenic and that exposure to IL-23 is crucial for their ability to induce autoimmunity. 11, 14, 38, 39 To investigate the regulation of nonpathogenic and pathogenic Th17 cell development by IL-10, we purified naive CD4 þ T cells from WT and IL-10 À/À mice and activated the cells under either nonpathogenic conditions or pathogenic conditions. The IL-17-single-positive cells were significantly increased in IL-10 À/À cell culture under nonpathogenic or pathogenic conditions compared with WT cell cultures. However, IL-17/IFN-g double-positive cells were significantly increased in IL-10 À/À cell cultures under only pathogenic Th17 conditions. In addition, the double-positive cells were also significantly increased in IL-10 À/À mice with GN. These results imply that IL-10 preferentially regulates pathogenic Th17 cell development. It is known that TGF-b1 is essential for nonpathogenic Th17 cell differentiation, whereas autonomously produced TGF-b3 from Th17 cells is critical in the induction of pathogenic Th17 cells. 11 Although the present study demonstrated that IL-10 is clearly involved in the regulation of pathogenic Th17 cell induction, the molecular mechanisms underlying this phenomenon are incompletely understood. A future study will focus on the regulation of key transcription factors, including RORgt, IRF4, Ahr, and TGF-b3, by IL-10 under pathogenic Th17 conditions. In summary, these studies clearly demonstrate that IL-10 
